These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 24553861

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Increased expression of USP22 is associated with disease progression and patient prognosis of salivary duct carcinoma.
    Piao S, Ma J, Wang W, Liu Y, Zhang M, Chen H, Guo F, Zhang B, Guo F.
    Oral Oncol; 2013 Aug; 49(8):796-801. PubMed ID: 23664741
    [Abstract] [Full Text] [Related]

  • 44. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
    Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T.
    Histopathology; 2017 Jan; 70(2):164-173. PubMed ID: 27079821
    [Abstract] [Full Text] [Related]

  • 45. Salivary duct carcinoma: evaluation of treatment and outcome in a tertiary referral institute.
    Beck ACC, Lohuis PJFM, Al-Mamgani A, Smit LA, Klop WMC.
    Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1885-1892. PubMed ID: 29785551
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma.
    Aoyama J, Nojima Y, Sano D, Hirai Y, Kijima N, Aizawa Y, Takada K, Hatano T, Takahashi H, Nishimura G, Oridate N.
    Head Neck; 2023 Jul; 45(7):1801-1811. PubMed ID: 37184432
    [Abstract] [Full Text] [Related]

  • 50. Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.
    Park JC, Ma TM, Rooper L, Hembrough T, Foss RD, Schmitt NC, Sawhney R, Flanders A, Kang H.
    Head Neck; 2018 Dec; 40(12):E100-E106. PubMed ID: 30478962
    [Abstract] [Full Text] [Related]

  • 51. Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma.
    Mitani Y, Lin SH, Pytynia KB, Ferrarotto R, El-Naggar AK.
    Clin Cancer Res; 2020 Mar 01; 26(5):1175-1184. PubMed ID: 31772120
    [Abstract] [Full Text] [Related]

  • 52. Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression.
    Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, Ud Din N, Purgina B, Lai C, Griffith CC, Chiosea SI.
    Am J Surg Pathol; 2015 May 01; 39(5):705-13. PubMed ID: 25871467
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified.
    Sousa LG, Wang K, Torman D, Binks BJ, Rubin ML, Andersen CR, Lewis WE, Rivera MJ, Kaya D, El-Naggar AK, Hanna EY, Esmaeli B, Frank SJ, Bell D, Glisson BS, Rodon J, Meric-Bernstam F, Lee JJ, Ferrarotto R.
    Cancer; 2022 Feb 01; 128(3):509-518. PubMed ID: 34661906
    [Abstract] [Full Text] [Related]

  • 58. Prognostic value of PSMA, c-MET and E-cadherin in salivary duct carcinoma.
    van Boxtel W, Uijen MJM, Verhaegh GW, Willems SM, Jonker MA, PALGA Group, Schalken JA, van Engen-van Grunsven ICH, van Herpen CML.
    Oral Oncol; 2020 Nov 01; 110():105018. PubMed ID: 33039794
    [Abstract] [Full Text] [Related]

  • 59. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
    Skálová A, Stárek, Kucerová V, Szépe P, Plank L.
    Pathol Res Pract; 2001 Nov 01; 197(9):621-6. PubMed ID: 11569926
    [Abstract] [Full Text] [Related]

  • 60. Salivary duct carcinoma with squamous differentiation: histomorphological and immunophenotypical analysis of six cases.
    Dababneh MN, Griffith CC, Magliocca KR, Stojanov IJ.
    Histopathology; 2024 Oct 01; 85(4):590-597. PubMed ID: 38828680
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.